If you're talking about keeping production lines going - this isn't really part of what no-IP would do. Someone would still need to operate and maintain production and distribution - however the competition to do this would drive costs down dramatically.

Also, high margins and no competitive pressure make research and dev methods stagnant - no IP + public research funding and FDA subsidies seems like a more effective system to me.